product summary
Loading...
company name :
R&D Systems
product type :
ELISA/assay
product name :
Human Osteoactivin/GPNMB DuoSet ELISA
catalog :
DY2550
quantity :
1 Kit (for 15 Plates)
price :
850 USD
more info or order :
R&D Systems product webpage
citations: 9
Reference
Kleytman N, Ruan J, Ruan A, Zhang B, Murugesan V, Lin H, et al. Incremental biomarker and clinical outcomes after switch from enzyme therapy to eliglustat substrate reduction therapy in Gaucher disease. Mol Genet Metab Rep. 2021;29:100798 pubmed publisher
Hüttenrauch M, Ogorek I, Klafki H, Otto M, Stadelmann C, Weggen S, et al. Glycoprotein NMB: a novel Alzheimer's disease associated marker expressed in a subset of activated microglia. Acta Neuropathol Commun. 2018;6:108 pubmed publisher
Bhattacharyya S, Feferman L, Sharma G, Tobacman J. Increased GPNMB, phospho-ERK1/2, and MMP-9 in cystic fibrosis in association with reduced arylsulfatase B. Mol Genet Metab. 2018;124:168-175 pubmed publisher
Ma J, Baker A, Calabro A, Derwin K. Exploratory study on the effect of osteoactivin on muscle regeneration in a rat volumetric muscle loss model. PLoS ONE. 2017;12:e0175853 pubmed publisher
Murugesan V, Liu J, Yang R, Lin H, Lischuk A, Pastores G, et al. Validating glycoprotein non-metastatic melanoma B (gpNMB, osteoactivin), a new biomarker of Gaucher disease. Blood Cells Mol Dis. 2018;68:47-53 pubmed publisher
Marques A, Gabriel T, Aten J, van Roomen C, Ottenhoff R, Claessen N, et al. Gpnmb Is a Potential Marker for the Visceral Pathology in Niemann-Pick Type C Disease. PLoS ONE. 2016;11:e0147208 pubmed publisher
Zigdon H, Savidor A, Levin Y, Meshcheriakova A, Schiffmann R, Futerman A. Identification of a biomarker in cerebrospinal fluid for neuronopathic forms of Gaucher disease. PLoS ONE. 2015;10:e0120194 pubmed publisher
Conway B, Manoharan D, Manoharan D, Jenks S, Dear J, McLachlan S, et al. Measuring urinary tubular biomarkers in type 2 diabetes does not add prognostic value beyond established risk factors. Kidney Int. 2012;82:812-8 pubmed publisher
Patel Chamberlin M, Wang Y, Satirapoj B, Phillips L, Nast C, Dai T, et al. Hematopoietic growth factor inducible neurokinin-1 (Gpnmb/Osteoactivin) is a biomarker of progressive renal injury across species. Kidney Int. 2011;79:1138-48 pubmed publisher
image
image 1 :
R&D Systems DY2550 image 1
Human Osteoactivin/ GPNMB ELISA Standard Curve
product information
master code :
DY2550
SKU :
DY2550
product name :
Human Osteoactivin/GPNMB DuoSet ELISA
unit size :
1 Kit (for 15 Plates)
description :
The Human Osteoactivin/GPNMB DuoSet ELISA from R&D Systems is a Solid Phase Sandwich ELISA that quantifies human Osteoactivin/GPNMB.
target :
Osteoactivin/GPNMB
category :
ELISAs
species :
Human
gene symbol :
GPNMB
kit type :
Solid Phase Sandwich ELISA
elisaRange :
125.00 - 8000 pg/mL
top caption :
Human Osteoactivin/ GPNMB ELISA Standard Curve
applications :
ELISA
USD :
850 USD
alt names :
DC-HIL, glycoprotein (transmembrane) nmb, glycoprotein NMB, GPNMB, HGFIN, HGFINglycoprotein nmb-like protein, NMBosteoactivin, Transmembrane glycoprotein HGFIN, transmembrane glycoprotein NMB
storage :
Store the unopened product at 2 - 8 ░C. Do not use past expiration date.
more info or order :
R&D Systems product webpage
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.